{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:12:58Z","timestamp":1787004778997,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1053\/beha.2000.0104","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"631-649","source":"Crossref","is-referenced-by-count":46,"title":["The risks of transfusion-transmitted infection: direct estimation and mathematical modelling"],"prefix":"10.1053","volume":"13","author":[{"given":"Steven H.","family":"Kleinman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2000.0104_RF1","first-page":"652","volume":"31","year":"1982","journal-title":"MMWR"},{"key":"10.1053\/beha.2000.0104_RF2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1537-2995.1998.38398222863.x","article-title":"Creutzfeld\u2013Jakob disease and transfusion safety: tilting at icebergs?","volume":"38","author":"Dodd","year":"1997","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1423-0410.1998.7530178.x","article-title":"Creutzfeld\u2013Jakob disease and the risk from blood or blood products","volume":"75","author":"Will","year":"1998","journal-title":"Vox Sanguinis"},{"key":"10.1053\/beha.2000.0104_RF4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1423-0410.1999.7720077.x","article-title":"The French Haemovigilance system","volume":"77","author":"Debeir","year":"1999","journal-title":"Vox Sanguinis"},{"key":"10.1053\/beha.2000.0104_RF5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1423-0410.1999.7720082.x","article-title":"Systems contributing to the assurance of transfusion safety in the United Kingdom","volume":"77","author":"Williamson","year":"1999","journal-title":"Vox Sanguinis"},{"key":"10.1053\/beha.2000.0104_RF6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0887-7963(99)80008-X","article-title":"Approaches to the detection of bacterial contamination in cellular blood products","volume":"13","author":"Mitchell","year":"1999","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1053\/beha.2000.0104_RF7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198104233041701","article-title":"Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The transfusion-transmitted viruses study","volume":"304","author":"Aach","year":"1981","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jama.1981.03320060032017","article-title":"Donor transaminase and recipient hepatitis. Impact on blood transfusion services","volume":"246","author":"Alter","year":"1981","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beha.2000.0104_RF9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7326\/0003-4819-117-7-554","article-title":"Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I\/II infections","volume":"117","author":"Nelson","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beha.2000.0104_RF10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1537-2995.1989.29789369672.x","article-title":"Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening: the Transfusion Safety Study\/NHLBI donor repository","volume":"29","author":"Kleinman","year":"1989","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF11","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1537-2995.1995.351196110900.x","article-title":"The Retrovirus Epidemiology Donor Study (REDS): rationale and methods","volume":"35","author":"Zuck","year":"1995","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF12","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM198911303212202","article-title":"Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis","volume":"321","author":"Alter","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199111073251901","article-title":"Hepatitis C virus infection in post-transfusion hepatitis\u2014an analysis with first- and second-generation assays","volume":"325","author":"Aach","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJM199703133361102","article-title":"The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease","volume":"336","author":"Alter","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hep.510300118","article-title":"Transfusion-associated TT virus infection and its relationship to liver disease","volume":"30","author":"Matsumoto","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/beha.2000.0104_RF16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199208063270601","article-title":"The declining risk of post-transfusion hepatitis C virus infection","volume":"327","author":"Donahue","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199211263272216","article-title":"Post-transfusion hepatitis C virus infection","volume":"327","author":"Nelson","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7326\/0003-4819-113-10-733","article-title":"Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations","volume":"113","author":"Donegan","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beha.2000.0104_RF19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1537-2995.1994.34694295061.x","article-title":"Transfusion transmission of retroviruses: human T-lymphotropic viruses types I and II compared with human immunodeficiency virus type 1","volume":"34","author":"Donegan","year":"1994","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/174.1.26","article-title":"Factors influencing HIV-1 transmission by blood transfusion","volume":"174","author":"Busch","year":"1996","journal-title":"Journal of Infectious Diseases"},{"key":"10.1053\/beha.2000.0104_RF21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199107043250101","article-title":"Evaluation of screened blood donations for human immunodeficiency virus type 1 by culture and DNA amplification of pooled cells","volume":"325","author":"Busch","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF22","first-page":"992","article-title":"The risk of HIV transmission by screened blood","volume":"36","author":"Vyas","year":"1996","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF23","series-title":"XXIII International Meeting of Basic Research in Chagas Disease. 4\u20138 November. Caxambu, Brazil","article-title":"Seroprevalence of T. cruzi infection among US blood donors born in Chagas endemic countries","author":"Williams","year":"1996"},{"key":"10.1053\/beha.2000.0104_RF24","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199212313272703","article-title":"Long term mortality after transfusion-associated non-A, non-B hepatitis","volume":"327","author":"Seeff","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF25","series-title":"Applications of Molecular Biology in Blood Transfusion","first-page":"123","article-title":"Evolving applications of nucleic acid amplification assays for prevention of virus transmission by blood components and derivatives","author":"Busch","year":"1997"},{"key":"10.1053\/beha.2000.0104_RF26","first-page":"181","volume":"45","year":"1996","journal-title":"MMWR"},{"key":"10.1053\/beha.2000.0104_RF27","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community-acquired hepatitis C in the United States","volume":"327","author":"Alter","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF28","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(94)92524-0","article-title":"HIV-1\/HIV-2 seronegativity in HIV-1 subtype O infected patients","volume":"343","author":"Loussert-Ajaka","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/beha.2000.0104_RF29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1537-2995.1998.38198141499.x","article-title":"New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays","volume":"38","author":"Jongerius","year":"1998","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1537-2995.2000.40050585.x","article-title":"False-negative testing errors in routine viral marker screening of blood donors","volume":"40","author":"Busch","year":"2000","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF31","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","article-title":"The risk of transfusion-transmitted viral infections","volume":"334","author":"Schreiber","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/tmrv.1997.0110155","article-title":"The incidence\/window period model and its use to assess the risk of transfusion-transmitted HIV and HCV infection","volume":"11","author":"Kleinman","year":"1997","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1053\/beha.2000.0104_RF33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1537-2995.1997.37697335159.x","article-title":"A method for estimating hepatitis B virus incidence rates in volunteer blood donors","volume":"37","author":"Korelitz","year":"1997","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF34","first-page":"91","article-title":"A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion","volume":"35","author":"Manns","year":"1992","journal-title":"International Journal of Cancer"},{"key":"10.1053\/beha.2000.0104_RF35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jmv.1890370310","article-title":"Patterns of serological markers in transfusion-transmitted hepatitis C infection using second generation HCV assays","volume":"37","author":"Lelie","year":"1992","journal-title":"Journal of Medical Virology"},{"key":"10.1053\/beha.2000.0104_RF36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/bmj.307.6912.1095","article-title":"Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection","volume":"307","author":"Mimms","year":"1993","journal-title":"British Medical Journal"},{"key":"10.1053\/beha.2000.0104_RF37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1537-2995.1994.34494233574.x","article-title":"Duration of time from onset of HIV-1 infectiousness to development of detectable antibody","volume":"34","author":"Petersen","year":"1994","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1537-2995.1995.35295125745.x","article-title":"Time course of detection of viral and serological markers preceding HIV-1 seroconversion; implications for blood and tissue donor screening","volume":"35","author":"Busch","year":"1995","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF39","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/infdis\/168.6.1490","article-title":"Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections","volume":"168","author":"Niu","year":"1993","journal-title":"Journal of Infectious Diseases"},{"key":"10.1053\/beha.2000.0104_RF40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9343(97)00077-6","article-title":"Time course of viremia and antibody seroconversion following primary HIV infection: implications for management of exposed health care workers","volume":"102","author":"Busch","year":"1997","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF41","series-title":"Time course and kinetics of HIV viremia during primary infection","author":"Busch","year":"1996"},{"key":"10.1053\/beha.2000.0104_RF42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1537-2995.1999.39070688.x","article-title":"Redefining the HIV-infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission","volume":"39","author":"Murphy","year":"1999","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF43","first-page":"106s","article-title":"A proposed new method to estimate hepatitis B incidence rates based on HbsAg marker","volume":"39","author":"Wright","year":"1999","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF44","first-page":"502","article-title":"Factors influencing postexposure immunoprophylaxis of hepatitis B virus infection with hepatitis B immune globulin. High deoxyribonucleic acid polymerase activity in the inocula of unsuccessful cases","volume":"82","author":"Masuko","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1053\/beha.2000.0104_RF45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1423-0410.1984.tb00083.x","article-title":"A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients","volume":"46","author":"Okochi","year":"1984","journal-title":"Vox Sanguinis"},{"key":"10.1053\/beha.2000.0104_RF46","doi-asserted-by":"crossref","DOI":"10.1001\/jama.284.2.229","article-title":"Trends in incidence and prevalence of major transfusion-transmissible viral infections in United States blood donors, 1991 to 1996","author":"Glynn","year":"2000","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beha.2000.0104_RF47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.280.1.42","article-title":"New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes","volume":"280","author":"Janssen","year":"1998","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beha.2000.0104_RF48","first-page":"80s","article-title":"HIV incidence in first time vs. repeat blood donors","volume":"38","author":"Busch","year":"1998","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1997.03540360035027","article-title":"Estimates of infectious disease risk factors in US blood donors","volume":"277","author":"Williams","year":"1997","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beha.2000.0104_RF50","first-page":"114s","article-title":"Do frequent donors have lower seroconversion rates?","volume":"39","author":"Schreiber","year":"1999","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1423-0410.1995.tb02538.x","article-title":"Improved detection of anti-HCV in post-transfusion hepatitis by a third generation ELISA","volume":"68","author":"Barrera","year":"1995","journal-title":"Vox Sanguinis"},{"key":"10.1053\/beha.2000.0104_RF52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0887-7963(99)80030-3","article-title":"PCR testing of plasma pools: from concept to reality","volume":"13","author":"Flanagan","year":"1999","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1053\/beha.2000.0104_RF53","first-page":"70s","article-title":"Sensitivity of HIV and HCV RNA detection by pooled genome amplification testing","volume":"38","author":"Stramer","year":"1998","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF54","first-page":"72s","article-title":"Dynamics of HCV viremia and seroconversion in transfusion acquired HCV infections","volume":"38","author":"Busch","year":"1998","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF55","first-page":"2s","article-title":"Replacement of HIV-1 p24 antigen screening with HIV-1 RNA nucleic acid testing (NAT) for whole blood donations","volume":"39","author":"Stramer","year":"1999","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF56","first-page":"82","article-title":"Seroconversion of HIV, HCV, and HBV in blood donors in 1996\u2014risk of virus transmission by blood products in Germany","volume":"25","author":"Gluck","year":"1998","journal-title":"Infusionstherapie Transfusionmed"},{"key":"10.1053\/beha.2000.0104_RF57","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJM199611213352115","article-title":"Transfusion-transmitted viral infection","volume":"335","author":"Courouce","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF58","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1537-2995.1997.371098016437.x","article-title":"Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency type 1 infections","volume":"37","author":"Busch","year":"1997","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF59","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1537-2995.1995.351196110893.x","article-title":"Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection","volume":"35","author":"Busch","year":"1995","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF60","unstructured":"Infectious disease testing for blood transfusions, 13, 1, 27, 1995"},{"key":"10.1053\/beha.2000.0104_RF61","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM199604113341516","article-title":"The risk of HIV transmission by screened blood","volume":"334","author":"Kinloch","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF62","first-page":"84s","article-title":"Investigational screening of whole blood donations for HIV-1 and HCV by nucleic acid testing (NAT)","volume":"39","author":"Stramer","year":"1999","journal-title":"Transfusion"},{"key":"10.1053\/beha.2000.0104_RF63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0887-7963(98)80031-X","article-title":"Hepatitis C lookback","volume":"12","author":"Goldman","year":"1998","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1053\/beha.2000.0104_RF64","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/infdis\/172.3.648","article-title":"Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS","volume":"172","author":"Operskalski","year":"1995","journal-title":"Journal of Infectious Diseases"},{"key":"10.1053\/beha.2000.0104_RF65","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM198704163161601","article-title":"A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army","volume":"316","author":"Seeff","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.48.2.315","article-title":"HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators","volume":"48","author":"Murphy","year":"1997","journal-title":"Neurology"},{"key":"10.1053\/beha.2000.0104_RF67","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.159.13.1485","article-title":"Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors","volume":"159","author":"Murphy","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/beha.2000.0104_RF68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJM199208063270610","article-title":"The risk of transfusion-transmitted infection","volume":"327","author":"Dodd","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF69","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199102073240605","article-title":"The nature of adverse events in hospitalized patients\u2014results of the Harvard Medical Practice Study II","volume":"324","author":"Leape","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2000.0104_RF70","unstructured":"United States General Accounting Office, Blood Supply: transfusion-associated risks, 1997"},{"key":"10.1053\/beha.2000.0104_RF71","series-title":"Risk Management in Blood Transfusion: the Virtue of Reality","first-page":"81","article-title":"Transfusion safety decisions in the 1990s: reactions to the past","author":"Kleinman","year":"1999"},{"key":"10.1053\/beha.2000.0104_RF72","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/0003-4819-127-10-199711150-00009","article-title":"Safety of the blood supply in the United States: opportunities and controversies","volume":"127","author":"AuBuchon","year":"1997","journal-title":"Annals of Internal Medicine"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169260090104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169260090104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T19:51:22Z","timestamp":1555012282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169260090104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S152169260090104X"],"URL":"https:\/\/doi.org\/10.1053\/beha.2000.0104","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}